155 related articles for article (PubMed ID: 28808744)
1. Comment on "Comparison of CT and PET/CT for biopsy guidance in oncological patients".
Chen L; Sun H
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):151. PubMed ID: 28808744
[No Abstract] [Full Text] [Related]
2. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
Cerci JJ; Tabacchi E; Bogoni M
PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
[TBL] [Abstract][Full Text] [Related]
3. Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer: Reply.
Goineau A; Supiot S
Clin Nucl Med; 2016 Sep; 41(9):746-7. PubMed ID: 27088390
[No Abstract] [Full Text] [Related]
4. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer.
Groheux D
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1417-1419. PubMed ID: 28573331
[No Abstract] [Full Text] [Related]
6. A Comparison of Near-Infrared Diffuse Optical Imaging and 18F-FDG PET/CT for the Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy.
Jiang S; Pogue BW
J Nucl Med; 2016 Aug; 57(8):1166-7. PubMed ID: 27103023
[No Abstract] [Full Text] [Related]
7. Interim FDG-PET/CT in Hodgkin lymphoma: what are we actually looking at?
Adams HJA; Kwee TC
Acta Oncol; 2018 Aug; 57(8):1128-1130. PubMed ID: 29463178
[No Abstract] [Full Text] [Related]
8.
Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
[TBL] [Abstract][Full Text] [Related]
9. [Multimodal imaging of breast cancer recurrence : Prospective intraindividual comparison of
Avanesov M; Derlin T
Radiologe; 2017 Jan; 57(1):1-3. PubMed ID: 27757490
[No Abstract] [Full Text] [Related]
10. SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?
Maffione AM; Giammarile F; Rubello D
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1692-1694. PubMed ID: 28638977
[No Abstract] [Full Text] [Related]
11. Diagnosis and staging of solid pseudopapillary neoplasms of the pancreas: The role of
Zizzo M; Manenti A; Lococo F; Pedrazzoli C
Pancreatology; 2018 Jun; 18(4):413-414. PubMed ID: 29459006
[No Abstract] [Full Text] [Related]
12. Re: FDG PET/CT Findings of Intracardiac Myeloid Sarcoma.
Sahu KK; Gautam A; Ailawadhi S
Clin Nucl Med; 2017 Mar; 42(3):242-245. PubMed ID: 27819854
[No Abstract] [Full Text] [Related]
13. answer for the "Diagnosis and staging of solid pseudopapillary neoplasms of the pancreas: the role of 18 1 F-FDG PET/CT scan".
Wei J; Wang P; Chen Q; Miao Y
Pancreatology; 2018 Sep; 18(6):689. PubMed ID: 29937363
[No Abstract] [Full Text] [Related]
14. Re: 18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
Sabour S
Clin Nucl Med; 2017 Dec; 42(12):990. PubMed ID: 28737578
[No Abstract] [Full Text] [Related]
15. Re: 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
Lococo F; Rufini V; Treglia G
Clin Nucl Med; 2017 Jan; 42(1):81. PubMed ID: 27607179
[No Abstract] [Full Text] [Related]
16. 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas: Reply.
Sundin A; Uhlén N; Axelsson R
Clin Nucl Med; 2017 Jan; 42(1):81-82. PubMed ID: 27607160
[No Abstract] [Full Text] [Related]
17. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
[TBL] [Abstract][Full Text] [Related]
18. The Role of 18F-FDG PET/CT Scan in Predicting Histological Type of Thymic Epithelial Tumors: Indications and Practical Clinical Considerations.
Lococo F
Thorac Cardiovasc Surg; 2018 Jun; 66(4):350-351. PubMed ID: 28728208
[No Abstract] [Full Text] [Related]
19. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532
[TBL] [Abstract][Full Text] [Related]
20. Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography, sonography, and sonographically guided fine-needle aspiration biopsy in the diagnosis of axillary lymph nodes in patients with breast cancer: comparison of diagnostic performance.
Sohn YM; Hong IK; Han K
J Ultrasound Med; 2014 Jun; 33(6):1013-21. PubMed ID: 24866608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
